diaziquone has been researched along with Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gibson, NW; Preusch, PC; Ross, D; Siegel, D | 1 |
| Bartolucci, AA; DeSimone, P; Kramer, B; Omura, GA | 1 |
2 other study(ies) available for diaziquone and Carcinoma
| Article | Year |
|---|---|
Metabolism of diaziquone by NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase): role in diaziquone-induced DNA damage and cytotoxicity in human colon carcinoma cells.
Topics: Animals; Antineoplastic Agents; Aziridines; Benzoquinones; Carcinoma; Cell Division; Chromatography, High Pressure Liquid; Colonic Neoplasms; Glutathione; Humans; In Vitro Techniques; Kinetics; Liver; NAD(P)H Dehydrogenase (Quinone); Oxidation-Reduction; Quinone Reductases; Rats; Spectrum Analysis; Tumor Cells, Cultured | 1990 |
Phase II evaluation of diaziquone in gastric and pancreatic cancers. A Southeastern Cancer Study Group Trial.
Topics: Aged; Aziridines; Azirines; Benzoquinones; Carcinoma; Drug Evaluation; Female; Humans; Male; Middle Aged; Pancreatic Neoplasms; Stomach Neoplasms | 1986 |